These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9744578)

  • 1. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures.
    Chao CC; Gekker G; Hu S; Kravitz F; Peterson PK
    Biochem Pharmacol; 1998 Aug; 56(3):397-404. PubMed ID: 9744578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes.
    Peterson PK; Gekker G; Lokensgard JR; Bidlack JM; Chang AC; Fang X; Portoghese PS
    Biochem Pharmacol; 2001 May; 61(9):1145-51. PubMed ID: 11301048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression.
    Chao CC; Hu S; Gekker G; Lokensgard JR; Heyes MP; Peterson PK
    Neuropharmacology; 2000; 39(1):150-60. PubMed ID: 10665828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa-opioid modulation of human microglial cell superoxide anion generation.
    Hu S; Peterson PK; Chao CC
    Biochem Pharmacol; 1998 Aug; 56(3):285-8. PubMed ID: 9744563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes.
    Sheng WS; Hu S; Lokensgard JR; Peterson PK
    Biochem Pharmacol; 2003 Jan; 65(1):9-14. PubMed ID: 12473373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages.
    Chao CC; Gekker G; Sheng WS; Hu S; Peterson PK
    Drug Alcohol Depend; 2001 Apr; 62(2):149-54. PubMed ID: 11245971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes.
    Lokensgard JR; Gekker G; Peterson PK
    Biochem Pharmacol; 2002 Mar; 63(6):1037-41. PubMed ID: 11931835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells.
    Gekker G; Hu S; Wentland MP; Bidlack JM; Lokensgard JR; Peterson PK
    J Pharmacol Exp Ther; 2004 May; 309(2):600-6. PubMed ID: 14757849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line.
    Parkhill AL; Bidlack JM
    Int Immunopharmacol; 2006 Jun; 6(6):1013-9. PubMed ID: 16644488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
    Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.
    Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY
    Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
    Zhao Y; Joshi AA; Aldrich JV; Murray TF
    Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion.
    Neudeck BL; Loeb J; Buck J
    Eur J Pharmacol; 2003 Apr; 467(1-3):81-4. PubMed ID: 12706459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway.
    Zhou Y; Wang Y; Wang X; Tian X; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Gu X; Wang Y; Li J; Pei J
    Cell Physiol Biochem; 2017; 44(5):1965-1979. PubMed ID: 29224002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys.
    Negus SS
    Psychopharmacology (Berl); 2004 Nov; 176(2):204-13. PubMed ID: 15112031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
    Tejeda HA; Chefer VI; Zapata A; Shippenberg TS
    Psychopharmacology (Berl); 2010 Jun; 210(2):231-40. PubMed ID: 20232058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
    Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
    Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.